The global ADC Drug CDMO Service market was valued at US$ 3390 million in 2025 and is anticipated to reach US$ 11270 million by 2032, at a CAGR of 19.0% from 2026 to 2032.

ADC Drug CDMO Service Market

ADC drugs, also known as antibody drug coupling agents, work by coupling small molecule drugs with antibodies through linkers to form drugs. These drugs combine the high targeting ability of antibodies with the strong killing power of chemical drugs, and are considered the most promising next-generation antibody technology. To reduce research and development costs, most ADC drug development worldwide chooses outsourcing, leveraging CDMO companies to enter clinical and market more quickly. CDMO services refer to pharmaceutical and biotechnology companies outsourcing the research and production of their drugs or biological products to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its ability to customize and specialize, which can meet the specific needs of different customers at different stages.

One of the primary drivers of the ADC drug CDMO market is the increasing demand for targeted therapies, particularly in oncology. Cancer remains a leading cause of death globally, and the traditional methods of chemotherapy, while effective, often come with severe side effects that limit their use. ADCs, which combine the targeting ability of monoclonal antibodies with the potency of cytotoxic drugs, offer a more precise and effective treatment option. By delivering the toxic drug directly to cancer cells, ADCs minimize damage to healthy tissues, thereby reducing adverse effects.

The demand for ADCs is expected to increase significantly due to their ability to treat a wide range of cancers, including breast cancer, leukemia, and lung cancer. As the pipeline for ADC drugs continues to expand, pharmaceutical companies are increasingly relying on CDMOs to support the development and manufacturing of these complex therapies.

This report delivers a comprehensive overview of the global ADC Drug CDMO Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding ADC Drug CDMO Service. The ADC Drug CDMO Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global ADC Drug CDMO Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist ADC Drug CDMO Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of ADC Drug CDMO Service Market Report

Report Metric	Details
Report Name	ADC Drug CDMO Service Market
Accounted market size in 2025	US$ 3390 million
Forecasted market size in 2032	US$ 11270 million
CAGR	19.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Cleavable Linkers Non-cleavable Linkers
Segment by Application	Small and Medium-sized Pharmaceutical Companies Large Pharmaceutical Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza Group, Merck KGaA, WuXi XDC, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Axplora, Aji Bio-Pharma, BSP Pharmaceuticals, Cerbios-Pharma, Goodwin Biotechnology, TOT Biopharm, Huadong Medicine, Innovent Biologics, Shanghai Henlius Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for ADC Drug CDMO Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is ADC Drug CDMO Service Market growing?

Ans: The ADC Drug CDMO Service Market witnessing a CAGR of 19.0% during the forecast period 2026-2032.

What is the ADC Drug CDMO Service Market size in 2032?

Ans: The ADC Drug CDMO Service Market size in 2032 will be US$ 11270 million.

Who are the main players in the ADC Drug CDMO Service Market report?

Ans: The main players in the ADC Drug CDMO Service Market are Lonza Group, Merck KGaA, WuXi XDC, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Axplora, Aji Bio-Pharma, BSP Pharmaceuticals, Cerbios-Pharma, Goodwin Biotechnology, TOT Biopharm, Huadong Medicine, Innovent Biologics, Shanghai Henlius Biotech

What are the Application segmentation covered in the ADC Drug CDMO Service Market report?

Ans: The Applications covered in the ADC Drug CDMO Service Market report are Small and Medium-sized Pharmaceutical Companies, Large Pharmaceutical Companies

What are the Type segmentation covered in the ADC Drug CDMO Service Market report?

Ans: The Types covered in the ADC Drug CDMO Service Market report are Cleavable Linkers, Non-cleavable Linkers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global ADC Drug CDMO Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cleavable Linkers

1.2.3 Non-cleavable Linkers

1.3 Market by Application

1.3.1 Global ADC Drug CDMO Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Small and Medium-sized Pharmaceutical Companies

1.3.3 Large Pharmaceutical Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global ADC Drug CDMO Service Market Perspective (2021–2032)

2.2 Global ADC Drug CDMO Service Growth Trends by Region

2.2.1 Global ADC Drug CDMO Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 ADC Drug CDMO Service Historic Market Size by Region (2021–2026)

2.2.3 ADC Drug CDMO Service Forecasted Market Size by Region (2027–2032)

2.3 ADC Drug CDMO Service Market Dynamics

2.3.1 ADC Drug CDMO Service Industry Trends

2.3.2 ADC Drug CDMO Service Market Drivers

2.3.3 ADC Drug CDMO Service Market Challenges

2.3.4 ADC Drug CDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top ADC Drug CDMO Service Players by Revenue

3.1.1 Global Top ADC Drug CDMO Service Players by Revenue (2021–2026)

3.1.2 Global ADC Drug CDMO Service Revenue Market Share by Players (2021–2026)

3.2 Global Top ADC Drug CDMO Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by ADC Drug CDMO Service Revenue

3.4 Global ADC Drug CDMO Service Market Concentration Ratio

3.4.1 Global ADC Drug CDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by ADC Drug CDMO Service Revenue in 2025

3.5 Global Key Players of ADC Drug CDMO Service Head Offices and Areas Served

3.6 Global Key Players of ADC Drug CDMO Service, Products and Applications

3.7 Global Key Players of ADC Drug CDMO Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 ADC Drug CDMO Service Breakdown Data by Type

4.1 Global ADC Drug CDMO Service Historic Market Size by Type (2021–2026)

4.2 Global ADC Drug CDMO Service Forecasted Market Size by Type (2027–2032)

5 ADC Drug CDMO Service Breakdown Data by Application

5.1 Global ADC Drug CDMO Service Historic Market Size by Application (2021–2026)

5.2 Global ADC Drug CDMO Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America ADC Drug CDMO Service Market Size (2021–2032)

6.2 North America ADC Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America ADC Drug CDMO Service Market Size by Country (2021–2026)

6.4 North America ADC Drug CDMO Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe ADC Drug CDMO Service Market Size (2021–2032)

7.2 Europe ADC Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe ADC Drug CDMO Service Market Size by Country (2021–2026)

7.4 Europe ADC Drug CDMO Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific ADC Drug CDMO Service Market Size (2021–2032)

8.2 Asia-Pacific ADC Drug CDMO Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific ADC Drug CDMO Service Market Size by Region (2021–2026)

8.4 Asia-Pacific ADC Drug CDMO Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America ADC Drug CDMO Service Market Size (2021–2032)

9.2 Latin America ADC Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America ADC Drug CDMO Service Market Size by Country (2021–2026)

9.4 Latin America ADC Drug CDMO Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa ADC Drug CDMO Service Market Size (2021–2032)

10.2 Middle East & Africa ADC Drug CDMO Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa ADC Drug CDMO Service Market Size by Country (2021–2026)

10.4 Middle East & Africa ADC Drug CDMO Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza Group

11.1.1 Lonza Group Company Details

11.1.2 Lonza Group Business Overview

11.1.3 Lonza Group ADC Drug CDMO Service Introduction

11.1.4 Lonza Group Revenue in ADC Drug CDMO Service Business (2021–2026)

11.1.5 Lonza Group Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Details

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA ADC Drug CDMO Service Introduction

11.2.4 Merck KGaA Revenue in ADC Drug CDMO Service Business (2021–2026)

11.2.5 Merck KGaA Recent Development

11.3 WuXi XDC

11.3.1 WuXi XDC Company Details

11.3.2 WuXi XDC Business Overview

11.3.3 WuXi XDC ADC Drug CDMO Service Introduction

11.3.4 WuXi XDC Revenue in ADC Drug CDMO Service Business (2021–2026)

11.3.5 WuXi XDC Recent Development

11.4 Abbvie

11.4.1 Abbvie Company Details

11.4.2 Abbvie Business Overview

11.4.3 Abbvie ADC Drug CDMO Service Introduction

11.4.4 Abbvie Revenue in ADC Drug CDMO Service Business (2021–2026)

11.4.5 Abbvie Recent Development

11.5 Piramal Pharma Solutions

11.5.1 Piramal Pharma Solutions Company Details

11.5.2 Piramal Pharma Solutions Business Overview

11.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Introduction

11.5.4 Piramal Pharma Solutions Revenue in ADC Drug CDMO Service Business (2021–2026)

11.5.5 Piramal Pharma Solutions Recent Development

11.6 Catalent

11.6.1 Catalent Company Details

11.6.2 Catalent Business Overview

11.6.3 Catalent ADC Drug CDMO Service Introduction

11.6.4 Catalent Revenue in ADC Drug CDMO Service Business (2021–2026)

11.6.5 Catalent Recent Development

11.7 Sterling Pharma Solutions

11.7.1 Sterling Pharma Solutions Company Details

11.7.2 Sterling Pharma Solutions Business Overview

11.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Introduction

11.7.4 Sterling Pharma Solutions Revenue in ADC Drug CDMO Service Business (2021–2026)

11.7.5 Sterling Pharma Solutions Recent Development

11.8 Axplora

11.8.1 Axplora Company Details

11.8.2 Axplora Business Overview

11.8.3 Axplora ADC Drug CDMO Service Introduction

11.8.4 Axplora Revenue in ADC Drug CDMO Service Business (2021–2026)

11.8.5 Axplora Recent Development

11.9 Aji Bio-Pharma

11.9.1 Aji Bio-Pharma Company Details

11.9.2 Aji Bio-Pharma Business Overview

11.9.3 Aji Bio-Pharma ADC Drug CDMO Service Introduction

11.9.4 Aji Bio-Pharma Revenue in ADC Drug CDMO Service Business (2021–2026)

11.9.5 Aji Bio-Pharma Recent Development

11.10 BSP Pharmaceuticals

11.10.1 BSP Pharmaceuticals Company Details

11.10.2 BSP Pharmaceuticals Business Overview

11.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Introduction

11.10.4 BSP Pharmaceuticals Revenue in ADC Drug CDMO Service Business (2021–2026)

11.10.5 BSP Pharmaceuticals Recent Development

11.11 Cerbios-Pharma

11.11.1 Cerbios-Pharma Company Details

11.11.2 Cerbios-Pharma Business Overview

11.11.3 Cerbios-Pharma ADC Drug CDMO Service Introduction

11.11.4 Cerbios-Pharma Revenue in ADC Drug CDMO Service Business (2021–2026)

11.11.5 Cerbios-Pharma Recent Development

11.12 Goodwin Biotechnology

11.12.1 Goodwin Biotechnology Company Details

11.12.2 Goodwin Biotechnology Business Overview

11.12.3 Goodwin Biotechnology ADC Drug CDMO Service Introduction

11.12.4 Goodwin Biotechnology Revenue in ADC Drug CDMO Service Business (2021–2026)

11.12.5 Goodwin Biotechnology Recent Development

11.13 TOT Biopharm

11.13.1 TOT Biopharm Company Details

11.13.2 TOT Biopharm Business Overview

11.13.3 TOT Biopharm ADC Drug CDMO Service Introduction

11.13.4 TOT Biopharm Revenue in ADC Drug CDMO Service Business (2021–2026)

11.13.5 TOT Biopharm Recent Development

11.14 Huadong Medicine

11.14.1 Huadong Medicine Company Details

11.14.2 Huadong Medicine Business Overview

11.14.3 Huadong Medicine ADC Drug CDMO Service Introduction

11.14.4 Huadong Medicine Revenue in ADC Drug CDMO Service Business (2021–2026)

11.14.5 Huadong Medicine Recent Development

11.15 Innovent Biologics

11.15.1 Innovent Biologics Company Details

11.15.2 Innovent Biologics Business Overview

11.15.3 Innovent Biologics ADC Drug CDMO Service Introduction

11.15.4 Innovent Biologics Revenue in ADC Drug CDMO Service Business (2021–2026)

11.15.5 Innovent Biologics Recent Development

11.16 Shanghai Henlius Biotech

11.16.1 Shanghai Henlius Biotech Company Details

11.16.2 Shanghai Henlius Biotech Business Overview

11.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Introduction

11.16.4 Shanghai Henlius Biotech Revenue in ADC Drug CDMO Service Business (2021–2026)

11.16.5 Shanghai Henlius Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

WuXi XDC

Axplora

Catalent

AbbVie

TOT BIOPHARM

Lonza Group

Merck KGaA

Piramal Pharma Solutions

Sterling Pharma Solutions

Aji Bio-Pharma

BSP Pharmaceuticals

Cerbios-Pharma

Goodwin Biotechnology

Huadong Medicine

Innovent Biologics

Shanghai Henlius Biotech

List of Tables

Table 1. Global ADC Drug CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cleavable Linkers

Table 3. Key Players of Non-cleavable Linkers

Table 4. Global ADC Drug CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global ADC Drug CDMO Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global ADC Drug CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 7. Global ADC Drug CDMO Service Market Share by Region (2021–2026)

Table 8. Global ADC Drug CDMO Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global ADC Drug CDMO Service Market Share by Region (2027–2032)

Table 10. ADC Drug CDMO Service Market Trends

Table 11. ADC Drug CDMO Service Market Drivers

Table 12. ADC Drug CDMO Service Market Challenges

Table 13. ADC Drug CDMO Service Market Restraints

Table 14. Global ADC Drug CDMO Service Revenue by Players (US$ Million), 2021–2026

Table 15. Global ADC Drug CDMO Service Market Share by Players (2021–2026)

Table 16. Global Top ADC Drug CDMO Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on ADC Drug CDMO Service Revenue, 2025

Table 17. Ranking of Global Top ADC Drug CDMO Service Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by ADC Drug CDMO Service Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of ADC Drug CDMO Service, Headquarters and Area Served

Table 20. Global Key Players of ADC Drug CDMO Service, Products and Applications

Table 21. Global Key Players of ADC Drug CDMO Service, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global ADC Drug CDMO Service Market Size by Type (US$ Million), 2021–2026

Table 24. Global ADC Drug CDMO Service Revenue Market Share by Type (2021–2026)

Table 25. Global ADC Drug CDMO Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global ADC Drug CDMO Service Revenue Market Share by Type (2027–2032)

Table 27. Global ADC Drug CDMO Service Market Size by Application (US$ Million), 2021–2026

Table 28. Global ADC Drug CDMO Service Revenue Market Share by Application (2021–2026)

Table 29. Global ADC Drug CDMO Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global ADC Drug CDMO Service Revenue Market Share by Application (2027–2032)

Table 31. North America ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America ADC Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 33. North America ADC Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 34. Europe ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe ADC Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 36. Europe ADC Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific ADC Drug CDMO Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific ADC Drug CDMO Service Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific ADC Drug CDMO Service Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America ADC Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America ADC Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa ADC Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa ADC Drug CDMO Service Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa ADC Drug CDMO Service Market Size by Country (US$ Million), 2027–2032

Table 46. Lonza Group Company Details

Table 47. Lonza Group Business Overview

Table 48. Lonza Group ADC Drug CDMO Service Product

Table 49. Lonza Group Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 50. Lonza Group Recent Development

Table 51. Merck KGaA Company Details

Table 52. Merck KGaA Business Overview

Table 53. Merck KGaA ADC Drug CDMO Service Product

Table 54. Merck KGaA Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 55. Merck KGaA Recent Development

Table 56. WuXi XDC Company Details

Table 57. WuXi XDC Business Overview

Table 58. WuXi XDC ADC Drug CDMO Service Product

Table 59. WuXi XDC Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 60. WuXi XDC Recent Development

Table 61. Abbvie Company Details

Table 62. Abbvie Business Overview

Table 63. Abbvie ADC Drug CDMO Service Product

Table 64. Abbvie Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 65. Abbvie Recent Development

Table 66. Piramal Pharma Solutions Company Details

Table 67. Piramal Pharma Solutions Business Overview

Table 68. Piramal Pharma Solutions ADC Drug CDMO Service Product

Table 69. Piramal Pharma Solutions Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 70. Piramal Pharma Solutions Recent Development

Table 71. Catalent Company Details

Table 72. Catalent Business Overview

Table 73. Catalent ADC Drug CDMO Service Product

Table 74. Catalent Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 75. Catalent Recent Development

Table 76. Sterling Pharma Solutions Company Details

Table 77. Sterling Pharma Solutions Business Overview

Table 78. Sterling Pharma Solutions ADC Drug CDMO Service Product

Table 79. Sterling Pharma Solutions Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 80. Sterling Pharma Solutions Recent Development

Table 81. Axplora Company Details

Table 82. Axplora Business Overview

Table 83. Axplora ADC Drug CDMO Service Product

Table 84. Axplora Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 85. Axplora Recent Development

Table 86. Aji Bio-Pharma Company Details

Table 87. Aji Bio-Pharma Business Overview

Table 88. Aji Bio-Pharma ADC Drug CDMO Service Product

Table 89. Aji Bio-Pharma Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 90. Aji Bio-Pharma Recent Development

Table 91. BSP Pharmaceuticals Company Details

Table 92. BSP Pharmaceuticals Business Overview

Table 93. BSP Pharmaceuticals ADC Drug CDMO Service Product

Table 94. BSP Pharmaceuticals Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 95. BSP Pharmaceuticals Recent Development

Table 96. Cerbios-Pharma Company Details

Table 97. Cerbios-Pharma Business Overview

Table 98. Cerbios-Pharma ADC Drug CDMO Service Product

Table 99. Cerbios-Pharma Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 100. Cerbios-Pharma Recent Development

Table 101. Goodwin Biotechnology Company Details

Table 102. Goodwin Biotechnology Business Overview

Table 103. Goodwin Biotechnology ADC Drug CDMO Service Product

Table 104. Goodwin Biotechnology Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 105. Goodwin Biotechnology Recent Development

Table 106. TOT Biopharm Company Details

Table 107. TOT Biopharm Business Overview

Table 108. TOT Biopharm ADC Drug CDMO Service Product

Table 109. TOT Biopharm Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 110. TOT Biopharm Recent Development

Table 111. Huadong Medicine Company Details

Table 112. Huadong Medicine Business Overview

Table 113. Huadong Medicine ADC Drug CDMO Service Product

Table 114. Huadong Medicine Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 115. Huadong Medicine Recent Development

Table 116. Innovent Biologics Company Details

Table 117. Innovent Biologics Business Overview

Table 118. Innovent Biologics ADC Drug CDMO Service Product

Table 119. Innovent Biologics Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 120. Innovent Biologics Recent Development

Table 121. Shanghai Henlius Biotech Company Details

Table 122. Shanghai Henlius Biotech Business Overview

Table 123. Shanghai Henlius Biotech ADC Drug CDMO Service Product

Table 124. Shanghai Henlius Biotech Revenue in ADC Drug CDMO Service Business (US$ Million), 2021–2026

Table 125. Shanghai Henlius Biotech Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. ADC Drug CDMO Service Picture

Figure 2. Global ADC Drug CDMO Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global ADC Drug CDMO Service Market Share by Type: 2025 vs 2032

Figure 4. Cleavable Linkers Features

Figure 5. Non-cleavable Linkers Features

Figure 6. Global ADC Drug CDMO Service Market Size by Application (US$ Million), 2021–2032

Figure 7. Global ADC Drug CDMO Service Market Share by Application: 2025 vs 2032

Figure 8. Small and Medium-sized Pharmaceutical Companies Case Studies

Figure 9. Large Pharmaceutical Companies Case Studies

Figure 10. ADC Drug CDMO Service Report Years Considered

Figure 11. Global ADC Drug CDMO Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 12. Global ADC Drug CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global ADC Drug CDMO Service Market Share by Region: 2025 vs 2032

Figure 14. Global ADC Drug CDMO Service Market Share by Players in 2025

Figure 15. Global ADC Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by ADC Drug CDMO Service Revenue in 2025

Figure 17. North America ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 18. North America ADC Drug CDMO Service Market Share by Country (2021–2032)

Figure 19. United States ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. Canada ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Europe ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe ADC Drug CDMO Service Market Share by Country (2021–2032)

Figure 23. Germany ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. France ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. U.K. ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Italy ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Russia ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Ireland ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Asia-Pacific ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific ADC Drug CDMO Service Market Share by Region (2021–2032)

Figure 31. China ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Japan ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. South Korea ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Southeast Asia ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. India ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Australia & New Zealand ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Latin America ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America ADC Drug CDMO Service Market Share by Country (2021–2032)

Figure 39. Mexico ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Brazil ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Middle East & Africa ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa ADC Drug CDMO Service Market Share by Country (2021–2032)

Figure 43. Israel ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Saudi Arabia ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. UAE ADC Drug CDMO Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Lonza Group Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 47. Merck KGaA Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 48. WuXi XDC Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 49. Abbvie Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 50. Piramal Pharma Solutions Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 51. Catalent Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 52. Sterling Pharma Solutions Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 53. Axplora Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 54. Aji Bio-Pharma Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 55. BSP Pharmaceuticals Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 56. Cerbios-Pharma Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 57. Goodwin Biotechnology Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 58. TOT Biopharm Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 59. Huadong Medicine Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 60. Innovent Biologics Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 61. Shanghai Henlius Biotech Revenue Growth Rate in ADC Drug CDMO Service Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antibody Drug CDMO Service Market Research Report 2024

Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025

Global Small Molecule Drug CDMO Services Market Research Report 2024

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemical Drug CDMO Market Research Report 2024

Global Pharmaceutical CDMO Market Research Report 2025

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Global ADC Manufacturing Service Market Research Report 2025

Global Small Molecules CDMO Services Market Research Report 2024

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Drug Conjugates PDCs CDMO Service Market Research Report 2024

Global ADC Linkers Market Research Report 2024

Global Monoclonal Antibody ADC Drugs Market Research Report 2025

Global Large Molecule Drug Substance CDMO Market Research Report 2024

Global Antibody drug Conjugates Market Insights Forecast to 2030

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Antibody drug Conjugates for Tumors Market Research Report 2024

Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Full Service CDMO Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions